Personalized Understanding and Management of Asthma and Allergy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 23760
Special Issue Editors
Interests: difficult-to-control asthma; allergy; lifecourse of asthma and allergy
Special Issue Information
Dear Colleagues,
The last 50 years have seen a significant rise in the global burden of asthma and allergic diseases, creating impact on both societal and individual patient levels. In parallel, there is now a growing understanding of the diverse nature of both asthma and allergic disease and the fact that these terms cover a spectrum of underlying phenotypes with differing mechanistic foundations. From this framework has arisen the drive to adopt personalised treatment approaches to successfully manage asthma and allergy in the 21st Century. This Special Issue of the Journal of Personalized Medicine aims to provide a clinically relevant understanding of advances in the personalised medicine approach to asthma and allergy using basic science, epidemiological, and clinical approaches. We would like to invite your contributions as a key expert in the field to this Special Issue and welcome your input with either original research articles or review articles. This is a great opportunity to publish your work as part of a core collection of articles on advances in asthma and allergy in the context of personalised medicine. So do please join us in this Special Issue.
Kind regards,
Dr. Ramesh J. Kurukulaaratchy
Dr. Hans Michael Haitchi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Asthma
- Allergy
- Biomarkers
- Biologic therapies
- Endotypes
- Personalized medicine
- Phenotypes
- Prediction
- Prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.